Blue Sparrow’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Blue Sparrow's NKTR Position: Q3 2026 in Review
Blue Sparrow opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 110,100 shares worth $6.67M. The stake represents 0.08% of the portfolio and ranks #133 among its holdings.
243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Blue Sparrow held 110,100 shares of Nektar Therapeutics worth $6.67M as of Q3 2026.
- Nektar Therapeutics was a new Blue Sparrow position in Q3 2026.
- Nektar Therapeutics made up 0.08% of Blue Sparrow's portfolio in Q3 2026, its #133 holding.
- 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Blue Sparrow's 13F filing for Q3 2026, filed 16 Nov 2026.